BridgeBio Pharma, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC BBIO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

451,016

Value ($000)

34,498

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	34,498	0.0%	451,016	12/31/2025
2025 Q3	11/14/2025	26,659	0.0%	513,263	9/30/2025
2025 Q2	8/14/2025	30,414	0.0%	704,357	6/30/2025
2025 Q1	5/19/2025	20,913	0.0%	604,946	3/31/2025
2024 Q4	2/14/2025	16,727	0.0%	609,588	12/31/2024
2024 Q3	11/14/2024	16,810	0.0%	660,265	9/30/2024
2024 Q2	8/14/2024	17,886	0.0%	706,127	6/30/2024
2024 Q1	5/15/2024	19,847	0.0%	641,895	3/31/2024
2023 Q4	2/14/2024	26,653	0.0%	660,218	12/31/2023
2023 Q3	11/13/2023	18,344	0.0%	695,633	9/30/2023
2023 Q2	8/11/2023	11,680	0.0%	704,486	6/30/2023
2023 Q1	5/15/2023	11,680	0.0%	704,486	3/31/2023
2022 Q4	2/14/2023	792	0.0%	103,965	12/31/2022
2022 Q3	11/14/2022	1,072	0.0%	107,838	9/30/2022
2022 Q2	8/12/2022	769	0.0%	84,688	6/30/2022
2022 Q1	5/16/2022	664	0.0%	65,459	3/31/2022
2021 Q4	2/14/2022	1,084	0.0%	64,961	12/31/2021
2021 Q3	11/15/2021	3,314	0.0%	70,696	9/30/2021
2021 Q2	8/16/2021	4,217	0.0%	69,183	6/30/2021
2021 Q1	5/14/2021	2,430	0.0%	39,441	3/31/2021
2020 Q4	3/1/2021	11,762	0.0%	165,402	12/31/2020
2020 Q3	11/13/2020	6,543	0.0%	174,395	9/30/2020
2020 Q2	8/14/2020	5,770	0.0%	176,951	6/30/2020
2020 Q1	5/15/2020	4,899	0.0%	168,946	3/31/2020
2019 Q4	2/14/2020	2,690	0.0%	76,734	12/31/2019